← Back to Search

Behavioral Intervention

Theta-Burst Stimulation for Language Disorders (TAFE Trial)

N/A
Recruiting
Research Sponsored by Georgia State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to study how transcranial magnetic stimulation impacts a person's reading ability. The researchers want to know how long the effects of this stimulation last and when they are most effective. They will

Who is the study for?
This trial is for individuals with reading and language disorders, as well as healthy control subjects. Participants must be willing to undergo cognitive testing, MRI scans, TMS stimulation, and perform various tasks related to language, reading, and motor skills.
What is being tested?
The study investigates the timing and effects of different types of transcranial magnetic stimulation (iTBS - excitatory; cTBS - inhibitory; Sham Stimulation) on reading speed, ease, accuracy, and overall language behavior.
What are the potential side effects?
Transcranial magnetic stimulation may cause discomfort at the site of application or headaches. Some people might experience temporary changes in brain function that could affect mood or cognition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: iTBS/ShamExperimental Treatment2 Interventions
Adults age 18-30 with typical reading and language abilities
Group II: cTBS/ShamExperimental Treatment2 Interventions
Adults age 18-30 with typical reading and language abilities
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sham Stimulation
2020
Completed Phase 3
~770
cTBS
2013
N/A
~50
iTBS
2019
Completed Phase 3
~640

Find a Location

Who is running the clinical trial?

Georgia State UniversityLead Sponsor
65 Previous Clinical Trials
30,656 Total Patients Enrolled
~33 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top